Biomarkers and Actionable Gene Mutations in Gastrointestinal Cancer

Course overview

Dr. Matkowskyj will review the role and repertoire of current biomarkers in gastrointestinal cancers including actionable mutation and alterations. She will provide real world examples of current biomarkers and their impact on clinical outcomes. Dr. Matkowskyj will share her personal experience with a recently approved companion diagnostic biomarker and conclude her talk with emerging biomarkers in the gastric cancer space. After this presentation, participants will be able to: 1. Review several existing biomarkers within the GI cancer space 2. Discuss a novel biomarker for a recently approved companion diagnostic 3. Review findings on emerging biomarkers in gastric carcinoma